1. Home
  2. LNKB vs SMTI Comparison

LNKB vs SMTI Comparison

Compare LNKB & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKB
  • SMTI
  • Stock Information
  • Founded
  • LNKB 2018
  • SMTI 1982
  • Country
  • LNKB United States
  • SMTI United States
  • Employees
  • LNKB N/A
  • SMTI N/A
  • Industry
  • LNKB
  • SMTI Medical/Dental Instruments
  • Sector
  • LNKB
  • SMTI Health Care
  • Exchange
  • LNKB Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • LNKB 236.7M
  • SMTI 256.9M
  • IPO Year
  • LNKB N/A
  • SMTI N/A
  • Fundamental
  • Price
  • LNKB $6.46
  • SMTI $32.95
  • Analyst Decision
  • LNKB Hold
  • SMTI Buy
  • Analyst Count
  • LNKB 1
  • SMTI 1
  • Target Price
  • LNKB $7.50
  • SMTI $44.00
  • AVG Volume (30 Days)
  • LNKB 44.2K
  • SMTI 28.8K
  • Earning Date
  • LNKB 10-25-2024
  • SMTI 11-11-2024
  • Dividend Yield
  • LNKB 4.82%
  • SMTI N/A
  • EPS Growth
  • LNKB N/A
  • SMTI N/A
  • EPS
  • LNKB N/A
  • SMTI N/A
  • Revenue
  • LNKB $68,142,000.00
  • SMTI $72,410,222.00
  • Revenue This Year
  • LNKB N/A
  • SMTI $26.97
  • Revenue Next Year
  • LNKB $4.03
  • SMTI $18.91
  • P/E Ratio
  • LNKB N/A
  • SMTI N/A
  • Revenue Growth
  • LNKB 101.22
  • SMTI 21.42
  • 52 Week Low
  • LNKB $5.86
  • SMTI $26.00
  • 52 Week High
  • LNKB $8.29
  • SMTI $43.25
  • Technical
  • Relative Strength Index (RSI)
  • LNKB 54.07
  • SMTI 56.84
  • Support Level
  • LNKB $6.16
  • SMTI $30.29
  • Resistance Level
  • LNKB $6.39
  • SMTI $32.51
  • Average True Range (ATR)
  • LNKB 0.13
  • SMTI 1.72
  • MACD
  • LNKB 0.00
  • SMTI 0.31
  • Stochastic Oscillator
  • LNKB 76.92
  • SMTI 100.00

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: